✨ Medicines Consent Notices




2380 NEW ZEALAND GAZETTE, No. 88 22 JULY 2010

Product: Savacol Antiseptic Mouth & Throat Rinse - Alcohol Free
Active Ingredient: Chlorhexidine gluconate 2mg/mL
Dosage Form: Mouthwash
New Zealand Sponsor: Colgate-Palmolive Limited (NZ)
Manufacturer: GABA International AG, Therwil, Switzerland

Dated this 15th day of July 2010.

JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go5655

Provisional Consent to the Distribution of New Medicines

Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: MeNZB
Active Ingredient: Neisseria meningitidis group B (strain NZ98/254) 25Β΅g
Dosage Form: Suspension for injection
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Vaccines and Diagnostics S.r.l, Sovicille, Italy
Note: This consent is valid for two years from the date of publication of this notice.

Product: Myambutol
Active Ingredient: Ethambutol hydrochloride 100mg
Dosage Form: Tablet
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: Custom Pharmaceuticals Limited (UK), Hove, United Kingdom
Note: This consent is valid for two years from the date of publication of this notice.

Product: Myambutol
Active Ingredient: Ethambutol hydrochloride 400mg
Dosage Form: Tablet
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: Cadila Pharmaceuticals Limited, Ahmedabad, India
Note: This consent is valid for two years from the date of publication of this notice.

Dated this 15th day of July 2010.

JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go5657

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Humalog (vial)
Active Ingredient: Insulin lispro 100U/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturers:
Lilly Technology Center, Indianapolis, United States of America
Lilly France SAS, Fegersheim, France

Product: Humalog (cartridge)
Active Ingredient: Insulin lispro 100U/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturers:
Lilly France SAS, Fegersheim, France
Eli Lilly Italia SpA, Florence, Italy

Dated this 15th day of July 2010.

JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go5656



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2010, No 88





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of New Medicines (continued from previous page)

πŸ₯ Health & Social Welfare
15 July 2010
Medicines, Distribution, Consent, Savacol Antiseptic Mouth & Throat Rinse, Chlorhexidine gluconate
  • JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health

πŸ₯ Provisional Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
15 July 2010
Medicines, Provisional Consent, Distribution, MeNZB, Myambutol, Ethambutol hydrochloride
  • JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
15 July 2010
Medicines, Distribution, Consent, Humalog, Insulin lispro
  • JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health